Literature DB >> 29121212

Effectiveness and safety of rivaroxaban vs. warfarin in patients 80+ years of age with non-valvular atrial fibrillation.

Craig I Coleman1,2, Erin R Weeda3, Elaine Nguyen4, Thomas J Bunz5, Nitesh A Sood6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29121212     DOI： 10.1093/ehjqcco/qcx044

Source DB:  PubMed          Journal:  Eur Heart J Qual Care Clin Outcomes        ISSN： 2058-1742


× No keyword cloud information.
  3 in total

1.  The use of anticoagulants in chronic kidney disease: Common point of view of cardiologists and nephrologists.

Authors:  Justyna Domienik-Karłowicz; Olga Tronina; Wojciech Lisik; Magdalena Durlik; Piotr Pruszczyk
Journal:  Cardiol J       Date:  2019-03-26       Impact factor: 2.737

2.  Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population.

Authors:  Alpesh Amin; Allison Keshishian; Oluwaseyi Dina; Amol Dhamane; Anagha Nadkarni; Eric Carda; Cristina Russ; Lisa Rosenblatt; Jack Mardekian; Huseyin Yuce; Christine L Baker
Journal:  J Thromb Thrombolysis       Date:  2019-08       Impact factor: 2.300

3.  Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients.

Authors:  Steven Deitelzweig; Allison Keshishian; Xiaoyan Li; Amiee Kang; Amol D Dhamane; Xuemei Luo; Neeraja Balachander; Lisa Rosenblatt; Jack Mardekian; Xianying Pan; Anagha Nadkarni; Manuela Di Fusco; Alessandra B Garcia Reeves; Huseyin Yuce; Gregory Y H Lip
Journal:  J Am Geriatr Soc       Date:  2019-05-21       Impact factor: 5.562
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.